BE539861A - - Google Patents

Info

Publication number
BE539861A
BE539861A BE539861DA BE539861A BE 539861 A BE539861 A BE 539861A BE 539861D A BE539861D A BE 539861DA BE 539861 A BE539861 A BE 539861A
Authority
BE
Belgium
Prior art keywords
sep
vaccine
virus
polio
poliomyelitis
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE539861A publication Critical patent/BE539861A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/13Poliovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE539861D BE539861A (cg-RX-API-DMAC10.html)

Publications (1)

Publication Number Publication Date
BE539861A true BE539861A (cg-RX-API-DMAC10.html)

Family

ID=169418

Family Applications (1)

Application Number Title Priority Date Filing Date
BE539861D BE539861A (cg-RX-API-DMAC10.html)

Country Status (1)

Country Link
BE (1) BE539861A (cg-RX-API-DMAC10.html)

Similar Documents

Publication Publication Date Title
Dobell et al. On the cultivation of Entamoeba histolytica and some other entozoic amoebae
EP0841942B1 (fr) Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu
FR2641447A1 (fr) Compositions virucides a faible toxicite
EP0007467A1 (fr) Vaccin antigrippal et procédé pour sa préparation
FR2483779A1 (fr) Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
Jörgensen Micro-organisms and Fermentation
EP0656055B1 (fr) Procede d'inactivation virale des produits plasmatiques par des fluides supercritiques ou subcritiques
BE539861A (cg-RX-API-DMAC10.html)
CA3202615A1 (fr) Milieu de culture, procede de fabrication et procede de culture bacterienne
BE1005589A3 (fr) Medicament pour le traitement de la dermatite.
Meynadier et al. Virose de type densonucleose chez les orthopteres
FR2499410A1 (fr) Vaccin contre l'avortement enzootique chez les brebis et son procede de preparation
CH340953A (fr) Procédé de stabilisation d'un vaccin contre la poliomyélite
EP1136074B1 (fr) Procédé d'extraction par un solvant de composés actifs de la chicorée
CH412201A (fr) Procédé de stabilisation d'un produit à base de virus antigène labile
EP0106831B1 (fr) Souches modifiées du virus de la diarrhée virale bovine, leur préparation et vaccins les contenant
BE669872A (fr) substances à activité biologique
FR2500476A1 (fr) Procede de reproduction de treponema pallidum virulent par culture sur tissu
BE1000255A4 (fr) Procede de preparation d'une souche de bordetella bronchiseptica mutante amelioree interessante comme vaccin vivant attenue conferant une protection contre les infections par b. bronchiseptica et vaccin ra vivant attenue que l'on en obtient.
Wilkinson THE DEVELOPMENT OF THE VIRUS CONCEPT AS REFLECTED IN CORPORA OF STUDIES ON INDIVIDUAL PATHOGENS*. 1. BEGINNINGS AT THE TURN OF THE CENTURY
Das et al. Vinegar from dates
BE554749A (cg-RX-API-DMAC10.html)
CN118667689A (zh) 一种融合魏斯氏菌及其应用
BE547257A (cg-RX-API-DMAC10.html)
BE560604A (cg-RX-API-DMAC10.html)